title: Functional FCGR3A 158 V/F and IL-6 -174 C/G polymorphisms predict response to biologic therapy in patients with rheumatoid arthritis: a meta-analysis.
abstract: The aim of this study was to investigate whether the Fc gamma receptor 3A (FCGR3A) 158 V/F and interleukin-6 (IL-6) promoter -174 G/C polymorphisms can predict the response to biologic-based therapy in patients with rheumatoid arthritis (RA). We conducted a meta-analysis of studies on the association between the FCGR3A V/F polymorphism or the IL-6 -174 C/G polymorphism and non-responsiveness to biologic therapy in RA patients. A total of 10 studies involving 1,427 patients were considered. These studies consisted of seven studies on the FCGR3A polymorphism and three studies on the IL-6 polymorphism. Meta-analysis showed no association between the FCGR3A VV+VF genotype and non-responders to biologic therapy [odds ratio (OR) 0.881, 95 % confidence interval (CI) 0.505-1.537, p = 0.655]. However, stratification by biologic type indicated an association between the FCGR3A VV+VF genotype and non-responders to rituximab (OR 0.566, 95 % CI 0.373-0.857, p = 0.007), but no association was found in non-responders to tumor necrosis factor (TNF)-blockers (OR 1.337, 95 % CI 0.869-2.056, p = 0.186). Meta-analysis revealed no association between the IL-6 CC+CG genotype and non-responders to the biologics (OR 3.233, 95 % CI 0.766-13.64, p = 0.110). However, an association was found between the IL-6 CC+CG genotype and non-responders to anti-TNF therapy (OR 8.030, 95 % CI 1.807-33.68, p = 0.006). This meta-analysis demonstrates that FCGR3A V allele carriers show a better response to rituximab, and individuals carrying the IL-6 -174 C allele show a poorer response to anti-TNF therapy for RA. Genotyping for these polymorphisms may be a useful tool for predicting the response to biologics with respect to personalized medicine.
authors.affiliation: Division of Rheumatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Korea University Medical Center, 126-1 ga, Anam-dong, Seongbuk-gu, Seoul, 136-705, Korea, lyhcgh@korea.ac.kr.
authors.forename: Young Ho
authors.initials: YH
authors.lastname: Lee
authors.forename: Sang-Cheol
authors.initials: SC
authors.lastname: Bae
authors.forename: Gwan Gyu
authors.initials: GG
authors.lastname: Song
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000235:genetics*; D001688:Biological Products / Q000627:therapeutic use*; D056726:Genetic Association Studies; D006801:Humans; D015850:Interleukin-6 / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D017452:Receptors, IgG / Q000235:genetics*; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products; C496124:FCGR3A protein, human; D015850:Interleukin-6; D017452:Receptors, IgG
references.citation: Ann Rheum Dis. 2009 Oct;68(10):1547-52
references.pmid: 18930989
references.citation: Blood. 1997 Aug 1;90(3):1109-14
references.pmid: 9242542
references.citation: Exp Dermatol. 1995 Feb;4(1):52-7
references.pmid: 7757333
references.citation: Inflamm Res. 2012 Jul;61(7):665-71
references.pmid: 22427231
references.citation: Rheumatology (Oxford). 2006 Feb;45(2):166-70
references.pmid: 16278286
references.citation: Arthritis Rheum. 2002 Jun;46(6):1443-50
references.pmid: 12115173
references.citation: Hum Genet. 2005 Nov;118(2):225-34
references.pmid: 16133175
references.citation: Rheumatol Int. 2013 Jun;33(6):1481-6
references.pmid: 23233117
references.citation: Blood. 1994 Jan 15;83(2):435-45
references.pmid: 7506951
references.citation: Autoimmun Rev. 2012 Mar;11(5):315-20
references.pmid: 20974296
references.citation: Br J Rheumatol. 1992 May;31(5):293-8
references.pmid: 1581770
references.citation: BMJ Open. 2012 Sep 22;2(5):
references.pmid: 23002160
references.citation: Science. 1999 Oct 15;286(5439):487-91
references.pmid: 10521338
references.citation: Curr Opin Rheumatol. 2003 May;15(3):246-52
references.pmid: 12707577
references.citation: Arthritis Rheum. 2001 Oct;44(10):2224-34
references.pmid: 11665962
references.citation: Annu Rev Immunol. 2001;19:275-90
references.pmid: 11244038
references.citation: Circulation. 2001 May 8;103(18):2260-5
references.pmid: 11342474
references.citation: Autoimmun Rev. 2009 Jun;8(7):538-42
references.pmid: 19189867
references.citation: Cytokine. 1999 Oct;11(10):789-95
references.pmid: 10525318
references.citation: Control Clin Trials. 1986 Sep;7(3):177-88
references.pmid: 3802833
references.citation: Stat Med. 2002 Jun 15;21(11):1539-58
references.pmid: 12111919
references.citation: Pharmacogenet Genomics. 2014 Jan;24(1):1-5
references.pmid: 24253594
references.citation: Nat Med. 2000 Apr;6(4):443-6
references.pmid: 10742152
references.citation: BMJ. 1997 Dec 6;315(7121):1533-7
references.pmid: 9432252
references.citation: Hum Genet. 2005 Dec;118(3-4):434-43
references.pmid: 16208513
references.citation: Arthritis Rheum. 2007 Feb;56(2):448-52
references.pmid: 17265480
references.citation: Arthritis Rheum. 2003 Jan;48(1):35-45
references.pmid: 12528101
references.citation: Rheumatol Int. 2006 Dec;27(2):157-61
references.pmid: 16909270
references.citation: Lancet. 1997 Oct 18;350(9085):1182
references.pmid: 9343537
references.citation: Ann Rheum Dis. 2008 Dec;67(12):1791-2
references.pmid: 19005160
references.citation: Best Pract Res Clin Rheumatol. 2001 Mar;15(1):67-76
references.pmid: 11358415
references.citation: J Rheumatol. 2008 Nov;35(11):2129-35
references.pmid: 18843786
references.citation: Arthritis Rheum. 2005 Jan;52(1):61-72
references.pmid: 15641091
references.citation: Ann Rheum Dis. 2014 Apr;73(4):716-21
references.pmid: 23505228
references.citation: Scand J Rheumatol. 2010 Nov;39(6):518-20
references.pmid: 20560817
references.citation: N Engl J Med. 1990 May 3;322(18):1277-89
references.pmid: 2271017
references.citation: Ann Intern Med. 2002 Jun 18;136(12):908-22
references.pmid: 12069565
references.citation: Ann Rheum Dis. 2009 Jun;68(6):954-60
references.pmid: 18490431
references.citation: Eur J Hum Genet. 2006 Mar;14(3):364-71
references.pmid: 16418737
references.citation: J Clin Invest. 1998 Oct 1;102(7):1369-76
references.pmid: 9769329
references.citation: Ann Rheum Dis. 2012 Jun;71(6):875-7
references.pmid: 22368231
references.citation: Arthritis Rheum. 2005 Sep;52(9):2693-6
references.pmid: 16142749